Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Inflammatory arthritis
Questions discussed in this category
When would you consider utilizing bone scintigraphy in the assessment of inflammatory arthritis?
2 Answers available
How do you approach differentiating infectious vs inflammatory tenosynovitis?
1 Answer available
Do you stop TNF inhibitors during the third trimester of pregnancy?
2 Answers available
Is it safe to treat checkpoint inhibitor-induced arthritis with methotrexate or biologics?
1 Answer available
How would you treat inflammatory arthritis in a patient with Sjogren's syndrome and ILD (on mycophenolate) that is not responsive to hydroxychloroquine?
1 Answer available
How do you approach the continued use of TNF inhibitors in a patient with inflammatory arthritis who develops a positive dsDNA without clinical evidence of drug-induced lupus?
2 Answers available
How long would you treat with antimycobacterials before starting biologic DMARD in a patient with latent TB and active rheumatoid arthritis?
1 Answer available
How do you advise patients who had autoimmune diseases "triggered" by COVID infections on getting COVID vaccination?
E.g., inflammatory polyarthritis or inflammatory myopathy with onset within 2 weeks of documented COVID infection
1 Answer available
How do you manage arthralgias with subclinical synovitis seen on US or MRI?
1 Answer available
14030
15388
10502
8075
16352
13129
10497
9613
9022
Papers discussed in this category
Ann. Rheum. Dis., 2019 Sep 20
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation.
Lancet Rheumatol, 2021 Apr 06
Incident systemic rheumatic disease following COVID-19.
N Engl J Med, 2020 Nov 20
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
Arthritis Rheum,
Tuberculosis associated with therapy against tumor necrosis factor alpha.
Autoimmun Rev, 2012 Nov 30
Immunogenicity and autoimmunity during anti-TNF therapy.
Chest, 2021 Feb
Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.
Related Topics
Rheumatology
General Rheumatology
Internal Medicine
Rheumatoid Arthritis
TNF inhibitor
Gastroenterology
COVID-19
Inflammatory Bowel Disease
Osteoarthritis
Nuclear Medicine